we conclude that lhn-1 at these doses does not cross the placenta during the second trimester of pregnancy to suggest that lhn-1 may be a safe alternative to heparin in the management of the thromboembolic complications during pregnancy .
C0032980
second trimester
C0032961
pregnancy